A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis

Published 2016 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis
Authors
Keywords
-
Journal
HAEMATOLOGICA
Volume 102, Issue 1, Pages 94-102
Publisher
Ferrata Storti Foundation (Haematologica)
Online
2016-09-16
DOI
10.3324/haematol.2016.148924

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.